Atlas Trials

Influenza A Virus, H5N1 Subtype

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Influenza A Virus, H5N1 Subtype

RecordFirmDate
Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59 (NCT03497845)Biomedical Advanced Research and Development Authority2018-03-15
Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine (NCT02107807)Seqirus2014-04-01
Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03) (NCT01910519)National Institute of Allergy and Infectious Diseases (NIAID)2013-07-01
An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re... (NCT01086657)National Institute of Allergy and Infectious Diseases (NIAID)2010-02-25
Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally (NCT00489931)National Institute of Allergy and Infectious Diseases (NIAID)2007-06-18
Safety Study of Avian Flu Vaccine (NCT00408109)National Institute of Allergy and Infectious Diseases (NIAID)2006-12-04

Track Influenza A Virus, H5N1 Subtype automatically

Every clearance here is in the API, with alerts when new ones post.